15.3 Virulence Factors of Bacterial and Viral Pathogens

Bacterial Virulence Factors

Virulence factors are the specific molecules and structures that pathogens use to cause disease. They work by helping the pathogen invade host tissues, evade immune defenses, and damage host cells. The symptoms you associate with an infection (fever, inflammation, tissue destruction) come from two sources: direct damage caused by these virulence factors and your own immune system's response to the invasion.

Endotoxins vs. Exotoxins

These are the two major categories of bacterial toxins, and they differ in almost every way.

Endotoxins are lipopolysaccharide (LPS) molecules embedded in the outer membrane of gram-negative bacteria. They aren't actively secreted. Instead, they're released when the bacterial cell lyses (breaks apart) or divides. Endotoxins are heat-stable, meaning you can't destroy them just by boiling. Their effects are broad rather than targeted: they trigger a strong innate immune response that causes inflammation, fever, and in severe cases, septic shock. The lipid A portion of LPS is the component responsible for toxicity.

Exotoxins are proteins actively secreted by living bacteria (both gram-positive and gram-negative). Unlike endotoxins, they are heat-labile, so heat or chemical treatment can denature and inactivate them. Exotoxins are highly specific in their effects, targeting particular cell types or disrupting particular cellular functions. Because they're secreted, they can act at sites far from the original infection. Bacteria often deliver exotoxins through specialized secretion systems (like the Type III secretion system, which works like a molecular syringe to inject proteins directly into host cells).

Types of Exotoxins

A-B toxins have two functional subunits. The B (binding) subunit attaches to a specific receptor on the host cell surface, and this allows the A (active) subunit to enter the cell. Once inside, the A subunit has enzymatic activity that disrupts normal cell function. For example:

• Cholera toxin (from Vibrio cholerae): The A subunit locks a G protein in its active state, causing intestinal cells to pump out massive amounts of chloride and water, producing severe watery diarrhea.
• Diphtheria toxin (from Corynebacterium diphtheriae): The A subunit inhibits protein synthesis by inactivating elongation factor EF-2, killing host cells.
• Anthrax toxin (from Bacillus anthracis): Actually a three-component system where protective antigen (the B component) delivers two different A components (lethal factor and edema factor) into host cells.

Membrane-disrupting toxins form pores in host cell membranes, which destroys the cell's ability to maintain its internal environment and leads to lysis. Examples include streptolysin O from Streptococcus pyogenes and alpha-toxin from Clostridium perfringens.

Superantigens are particularly dangerous because they bypass normal antigen processing entirely. Normally, T cells only activate when they recognize a specific antigen presented by an antigen-presenting cell. Superantigens short-circuit this by cross-linking MHC II molecules on antigen-presenting cells directly to T cell receptors, regardless of antigen specificity. This activates up to 20% of all T cells at once (compared to the normal 0.001%), triggering a massive release of cytokines (a "cytokine storm") that can cause fever, dangerously low blood pressure, and organ failure. Toxic shock syndrome toxin-1 (TSST-1) from Staphylococcus aureus and staphylococcal enterotoxins are classic examples.

Regulation and Delivery of Virulence Factors

Bacteria don't produce virulence factors all the time. Virulence gene regulation allows bacteria to sense their environment and turn on virulence genes only when needed, such as when they detect they're inside a host. This conserves energy and helps avoid triggering immune detection prematurely.

Bacterial secretion systems (Types I through VI) are molecular machines that transport virulence factors across bacterial membranes and, in some cases, directly into host cells. The Type III secretion system, for instance, assembles a needle-like structure that punctures the host cell membrane and injects effector proteins.

Immune evasion strategies include producing capsules that resist phagocytosis, secreting proteases that degrade antibodies, and varying surface antigens to stay ahead of the adaptive immune response.

Viral Virulence Factors

Viral Strategies for Host Invasion

Viral infection begins with adhesion: viral surface proteins bind to specific receptors on host cells. This interaction determines which cell types and which species a virus can infect (its tropism). Two well-studied examples:

• Influenza virus uses its hemagglutinin protein to bind sialic acid residues on respiratory epithelial cells.
• HIV uses its gp120 protein to bind CD4 receptors on helper T cells and macrophages, then requires a co-receptor (CCR5 or CXCR4) for membrane fusion and entry.

Once inside, viruses face the host immune system. They've evolved several strategies to evade it:

1. Antigenic drift: Small mutations accumulate in genes encoding viral surface proteins, gradually changing their shape enough that existing antibodies no longer recognize them. This is why you need a new flu vaccine each year.
2. Antigenic shift: Entire genome segments are swapped between different viral strains (reassortment), producing dramatically new surface proteins. This only happens in viruses with segmented genomes, like influenza A, and can cause pandemics because the population has no pre-existing immunity.
3. Interference with immune signaling: Some viral proteins directly block host defense pathways. The influenza NS1 protein inhibits interferon production, weakening the antiviral state in surrounding cells. The herpes simplex virus ICP47 protein blocks the TAP transporter, preventing viral peptides from being loaded onto MHC I molecules, so infected cells can't signal cytotoxic T cells.
4. Latency and integration: Retroviruses like HIV integrate their genome into the host's DNA, becoming invisible to immune surveillance. Herpesviruses establish latency in specific cell types (neurons for HSV, B cells for EBV), remaining dormant with minimal gene expression until reactivation. During latency, the virus produces few or no proteins, so the immune system has nothing to detect.